Clene Inc. CLNN shares are trading lower by 13.81% to $0.90 Friday morning after the company announced pricing of a $40 million public offering.
The offering consists of 50,000,000 shares of common stock and accompanying warrants. The combined offering price per share and warrant is $0.80.
All shares and warrants are offered by Clene and will be issued separately but purchased together. The offering is set to close around June 21, subject to customary closing conditions.
The net proceeds will be used for general corporate purposes, clinical development of CNM-Au8®, research and development and regulatory activities.
See Also: What's Going On With Nikola (NKLA) Shares
According to data from Benzinga Pro, CLNN has a 52-week high of $5.13 and a 52-week low of $0.82.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
